Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
64 | Drug and Therapeutics Bulletin | journal | 0.147 Q4 | 17 | 88 | 258 | 1010 | 76 | 137 | 0.31 | 11.48 | |
63 | Drugs and Therapy Perspectives | journal | 0.188 Q3 | 13 | 71 | 236 | 1593 | 196 | 212 | 0.49 | 22.44 | |
62 | Expert Opinion on Orphan Drugs | journal | 0.199 Q3 | 27 | 3 | 85 | 174 | 66 | 82 | 0.86 | 58.00 | |
61 | Psychiatry and Clinical Psychopharmacology | journal | 0.220 Q3 | 24 | 42 | 171 | 1534 | 101 | 166 | 0.57 | 36.52 | |
60 | Journal of Pharmaceutical Health Care and Sciences | journal | 0.312 Q3 | 10 | 50 | 112 | 1283 | 145 | 111 | 1.28 | 25.66 | |
59 | Biopharmaceutics and Drug Disposition | journal | 0.396 Q3 | 65 | 36 | 91 | 1728 | 188 | 89 | 1.91 | 48.00 | |
58 | Journal of Oncology Pharmacy Practice | journal | 0.408 Q3 | 44 | 419 | 909 | 10302 | 1193 | 841 | 1.18 | 24.59 | |
57 | Journal of Chemotherapy | journal | 0.439 Q3 | 56 | 125 | 197 | 5160 | 347 | 179 | 1.80 | 41.28 | |
56 | Antiviral Therapy | journal | 0.447 Q3 | 93 | 24 | 105 | 935 | 154 | 102 | 1.45 | 38.96 | |
55 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q3 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | |
54 | International Journal of STD and AIDS | journal | 0.540 Q3 | 78 | 156 | 556 | 4040 | 810 | 535 | 1.35 | 25.90 | |
53 | Human Psychopharmacology | journal | 0.541 Q3 | 86 | 23 | 117 | 1225 | 246 | 116 | 1.98 | 53.26 | |
52 | Therapeutic Advances in Cardiovascular Disease | journal | 0.553 Q2 | 41 | 17 | 40 | 1230 | 95 | 37 | 2.48 | 72.35 | |
51 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.569 Q2 | 81 | 55 | 756 | 2389 | 1526 | 695 | 1.91 | 43.44 | |
50 | Fundamental and Clinical Pharmacology | journal | 0.586 Q2 | 85 | 110 | 288 | 7063 | 732 | 272 | 2.48 | 64.21 | |
49 | HIV Research and Clinical Practice | journal | 0.616 Q2 | 54 | 14 | 52 | 571 | 97 | 52 | 2.15 | 40.79 | |
48 | Expert Review of Pharmacoeconomics and Outcomes Research | journal | 0.671 Q2 | 61 | 118 | 329 | 5270 | 745 | 315 | 1.79 | 44.66 | |
47 | Clinical Drug Investigation | journal | 0.680 Q2 | 67 | 96 | 332 | 2966 | 860 | 305 | 2.63 | 30.90 | |
46 | Expert Opinion on Pharmacotherapy | journal | 0.687 Q2 | 93 | 206 | 669 | 15644 | 1640 | 573 | 2.15 | 75.94 | |
45 | Journal of Cannabis Research | journal | 0.692 Q2 | 17 | 39 | 148 | 1666 | 627 | 144 | 4.35 | 42.72 | |
44 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | |
43 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | |
42 | Therapeutic Advances in Vaccines and Immunotherapy | journal | 0.726 Q2 | 13 | 18 | 47 | 751 | 163 | 41 | 3.74 | 41.72 | |
41 | Pharmaceutical Medicine | journal | 0.732 Q2 | 25 | 47 | 107 | 2050 | 275 | 93 | 2.59 | 43.62 | |
40 | European Journal of Contraception and Reproductive Health Care | journal | 0.735 Q2 | 53 | 48 | 234 | 1508 | 447 | 215 | 1.80 | 31.42 | |
39 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | |
38 | American Journal of Cardiovascular Drugs | journal | 0.790 Q2 | 60 | 60 | 184 | 2987 | 512 | 174 | 2.66 | 49.78 | |
37 | Trials | journal | 0.812 Q2 | 98 | 802 | 2956 | 30481 | 6129 | 2785 | 1.93 | 38.01 | |
36 | Expert Review of Anticancer Therapy | journal | 0.827 Q2 | 85 | 123 | 370 | 8783 | 1034 | 330 | 2.78 | 71.41 | |
35 | AIDS Research and Therapy | journal | 0.872 Q2 | 49 | 89 | 234 | 3234 | 555 | 234 | 2.18 | 36.34 | |
34 | Expert Opinion on Emerging Drugs | journal | 0.881 Q1 | 54 | 29 | 110 | 2695 | 321 | 102 | 2.62 | 92.93 | |
33 | Drugs and Aging | journal | 0.894 Q1 | 109 | 86 | 254 | 5801 | 811 | 246 | 3.24 | 67.45 | |
32 | Expert Opinion on Drug Safety | journal | 0.905 Q1 | 90 | 165 | 441 | 8337 | 1384 | 401 | 3.03 | 50.53 | |
31 | Expert Review of Neurotherapeutics | journal | 0.957 Q1 | 98 | 108 | 322 | 11035 | 1154 | 289 | 3.25 | 102.18 | |
30 | Expert Review of Clinical Pharmacology | journal | 0.990 Q1 | 60 | 112 | 384 | 8775 | 1441 | 357 | 3.53 | 78.35 | |
29 | Paediatric Drugs | journal | 1.017 Q1 | 70 | 56 | 163 | 3652 | 629 | 158 | 3.52 | 65.21 | |
28 | Therapeutic Advances in Drug Safety | journal | 1.035 Q1 | 46 | 27 | 103 | 1296 | 396 | 91 | 3.07 | 48.00 | |
27 | British Journal of Clinical Pharmacology | journal | 1.046 Q1 | 167 | 409 | 1287 | 16426 | 4049 | 1111 | 3.04 | 40.16 | |
26 | HIV Medicine | journal | 1.052 Q1 | 86 | 151 | 348 | 5203 | 911 | 321 | 2.64 | 34.46 | |
25 | Advanced Therapeutics | journal | 1.063 Q1 | 39 | 159 | 324 | 12890 | 1482 | 319 | 4.31 | 81.07 | |
24 | Pharmaceutical Statistics | journal | 1.074 Q1 | 46 | 80 | 266 | 2401 | 460 | 252 | 1.77 | 30.01 | |
23 | Pharmacoepidemiology and Drug Safety | journal | 1.106 Q1 | 109 | 149 | 547 | 5012 | 1367 | 506 | 2.12 | 33.64 | |
22 | Clinical Pharmacokinetics | journal | 1.125 Q1 | 184 | 125 | 363 | 5322 | 1577 | 335 | 4.09 | 42.58 | |
21 | Therapeutic Advances in Respiratory Disease | journal | 1.179 Q1 | 50 | 78 | 206 | 3651 | 791 | 194 | 3.55 | 46.81 | |
20 | Orphanet Journal of Rare Diseases | journal | 1.182 Q1 | 136 | 386 | 1277 | 16047 | 4683 | 1226 | 3.33 | 41.57 | |
19 | Drug Safety | journal | 1.204 Q1 | 140 | 108 | 359 | 4530 | 1291 | 313 | 3.33 | 41.94 | |
18 | Antimicrobial Resistance and Infection Control | journal | 1.256 Q1 | 66 | 143 | 522 | 6549 | 2764 | 509 | 4.86 | 45.80 | |
17 | Journal of Antimicrobial Chemotherapy | journal | 1.271 Q1 | 221 | 417 | 1569 | 13480 | 6161 | 1374 | 3.35 | 32.33 | |
16 | Journal of Psychopharmacology | journal | 1.366 Q1 | 135 | 125 | 424 | 8028 | 1891 | 397 | 4.57 | 64.22 | |
15 | Cochrane Database of Systematic Reviews | journal | 1.408 Q1 | 327 | 536 | 2407 | 79418 | 10906 | 2382 | 4.03 | 148.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®